Company
»
»
About Us
Our Core Values
Our History
Our Mission
Core Competency
Quality Management
Manufacturing Facilities
Research and Development
Corporate Social Responsibility
Therapeutic Areas
Investors
»
»
Board of Directors
Corporate Governance
Code of Conduct
Stock Info
Abridged Annual Report
Green Initiative
Public Notice
Products
»
»
API
»
»
EU
USA
Other Pharmerging Markets
Notice for C&E Program
Dosage Forms
»
»
EU
Rest of World
Product Query
Careers
»
»
Current Openings
Policies
»
»
»
BMW reports
»
»
Kalyani
BMW AR-2021 Kalyani
BMW Authorisation Kalyani
Baddi
BMW Authorization Baddi
BMW AR-2021 Baddi
CSR Policy
Vigil Mechanism Policy
Prevention of Sexual Harassment Policy
Appointment Nomination and Remuneration Policy
Contact
Investors
Investors
Board of Directors
Corporate Governance
Code of Conduct
Stock Info
Dividend History
Public Notice
Overall Expertise
Manufacturing Facilities
Research & Development
Corporate Governance
Annual Reports
» 2022-23
» 2021-22
» 2020-21
» 2019-20
» 2018-19
» 2017-18
» 2016-17
» 2015-16
Shareholders and Stock Information
» Annual General Meeting
13th AGM Notice
14 AGM Notice
15 AGM Notice
16 AGM Notice
17 AGM Notice
18 AGM Notice
19 AGM Notice
20 AGM Notice
»
Details of unclaimed shares to be transferred to IEPF Authority
»
Details of unpaid dividend Transferred to IEPF
AGM 2013
AGM 2012
AGM 2011
Composition of CSR Committee
This is not hidden.
This is not hidden.
Top
© All Copyright Reserved | Fresenius Kabi Oncology Limited 2012
Data Protection
|
Imprint
|
Legal Disclaimer
|
Sitemap